Literature DB >> 8290561

Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y.

W Reith1, C A Siegrist, B Durand, E Barras, B Mach.   

Abstract

Transcription of major histocompatibility complex (MHC) class II genes is controlled largely by the conserved promoter elements called the X and Y boxes. We show here that RFX, the X box-binding protein deficient in certain MHC class II-deficient immunodeficiency patients (CID), and the Y box-binding protein NF-Y bind cooperatively. Functional relevance of this protein-protein interaction is suggested by the fact that promoter activity correlates with cooperative binding of RFX and NF-Y rather than with binding of RFX or NF-Y alone. Stability of the RFX/NF-Y complex is affected by alterations in X-Y box spacing. These results are consistent with the fact that MHC class II promoter function is dependent on correct stereospecific alignment of the X and Y boxes. Cooperative binding involving RFX, NF-Y, and perhaps other MHC class II promoter-binding proteins may explain why the highly specific defect in binding of RFX observed in CID cells is associated in vivo with a bare promoter in which all of the cis-acting elements, including the X and Y boxes, are unoccupied.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8290561      PMCID: PMC42987          DOI: 10.1073/pnas.91.2.554

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  NF-X, a transcription factor implicated in MHC class II gene regulation.

Authors:  V Kouskoff; R M Mantovani; S M Candéias; A Dorn; A Staub; B Lisowska-Grospierre; C Griscelli; C O Benoist; D J Mathis
Journal:  J Immunol       Date:  1991-05-01       Impact factor: 5.422

2.  Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome).

Authors:  V Steimle; L A Otten; M Zufferey; B Mach
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

3.  Protease treatment of nuclear extracts distinguishes between class II MHC X1 box DNA-binding proteins in wild-type and class II-deficient B cells.

Authors:  S L Hasegawa; J L Riley; J H Sloan; J M Boss
Journal:  J Immunol       Date:  1993-03-01       Impact factor: 5.422

Review 4.  Synergism in transcriptional activation: a kinetic view.

Authors:  D Herschlag; F B Johnson
Journal:  Genes Dev       Date:  1993-02       Impact factor: 11.361

5.  Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X.

Authors:  W Reith; S Satola; C H Sanchez; I Amaldi; B Lisowska-Grospierre; C Griscelli; M R Hadam; B Mach
Journal:  Cell       Date:  1988-06-17       Impact factor: 41.582

Review 6.  Regulation of MHC gene expression.

Authors:  J P Ting; A S Baldwin
Journal:  Curr Opin Immunol       Date:  1993-02       Impact factor: 7.486

7.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

8.  RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancer.

Authors:  C A Siegrist; B Durand; P Emery; E David; P Hearing; B Mach; W Reith
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

9.  An enhancer factor defect in a mutant Burkitt lymphoma cell line.

Authors:  W Koch; S Candeias; J Guardiola; R Accolla; C Benoist; D Mathis
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

Review 10.  Organ-specific autoimmunity: a 1986 overview.

Authors:  G F Bottazzo; I Todd; R Mirakian; A Belfiore; R Pujol-Borrell
Journal:  Immunol Rev       Date:  1986-12       Impact factor: 12.988

View more
  53 in total

1.  CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.

Authors:  K Masternak; A Muhlethaler-Mottet; J Villard; M Zufferey; V Steimle; W Reith
Journal:  Genes Dev       Date:  2000-05-01       Impact factor: 11.361

2.  Self-association of CIITA and its transactivation potential.

Authors:  T J Sisk; S Roys; C H Chang
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

3.  Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.

Authors:  Krzysztof Masternak; Walter Reith
Journal:  EMBO J       Date:  2002-03-15       Impact factor: 11.598

4.  Expression of the three human major histocompatibility complex class II isotypes exhibits a differential dependence on the transcription factor RFXAP.

Authors:  M Peretti; J Villard; E Barras; M Zufferey; W Reith
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

5.  Associations and interactions between bare lymphocyte syndrome factors.

Authors:  A M DeSandro; U M Nagarajan; J M Boss
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

6.  CIITA regulates transcription onset viaSer5-phosphorylation of RNA Pol II.

Authors:  Charalambos Spilianakis; Androniki Kretsovali; Theodora Agalioti; Takis Makatounakis; Dimitris Thanos; Joseph Papamatheakis
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

Review 7.  Impaired regulation of HLA-DR expression in human immunodeficiency virus-infected monocytes.

Authors:  Ling Shao; Kirk Sperber
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

8.  Modulation of DNA topoisomerase II alpha promoter activity by members of the Sp (specificity protein) and NF-Y (nuclear factor Y) families of transcription factors.

Authors:  Natisha Magan; Agnieszka P Szremska; Richard J Isaacs; Kathryn M Stowell
Journal:  Biochem J       Date:  2003-09-15       Impact factor: 3.857

Review 9.  Novel mechanisms of class II major histocompatibility complex gene regulation.

Authors:  Michael Radosevich; Santa Jeremy Ono
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

10.  The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element.

Authors:  J A Brown; E M Rogers; J M Boss
Journal:  Nucleic Acids Res       Date:  1998-09-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.